Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials-Reference-Cited by-同舟云学术

Risk of grade 3-4 diarrhea and mucositis in colorectal cancer patients receiving anti-EGFR monoclonal antibodies regimens: A meta-analysis of 18 randomized controlled clinical trials

Published:2015-11 Issue:2 Volume:96 Page:355-371
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Miroddi Marco,Sterrantino Carmelo,Simonelli Ilaria,Ciminata Giorgio,Phillips Robert S.,Calapai Gioacchino

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference61 articles.

1. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer;Ouwerkerk;Eur. J. Oncol. Nurs.,2010

2. Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis;Petrelli;Int. J. Colorectal Dis.,2011

3. Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis;Vale;Cancer Treat. Rev.,2012

4. Pharmacokinetic and pharmacodynamic perspectives on the clinical drug development of panitumumab;Yang;Clin. Pharmacokinet.,2010

5. Dual targeting of EGFR and HER-2 in colon cancer cell lines;Giannopoulou;Cancer Chemother. Pharmacol.,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant-Derived Polyphenols to Prevent and Treat Oral Mucositis Induced by Chemo- and Radiotherapy in Head and Neck Cancers Management;Cancers;2024-01-06

2. Anti-epidermal growth factor receptor targeted therapy-associated ulcerations;Oral Oncology;2024-01

3. Clinical characterization of stomatitis cases with an epithelial growth factor receptor inhibitor in metastatic colorectal cancer patients: A study of 7 cases and literature review;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2023-08

4. Pathogenesis of Oral Toxicities Associated with Targeted Therapy and Immunotherapy;International Journal of Molecular Sciences;2023-05-03

5. Gastrointestinal injury induced by immunomodulators: A review article;Therapeutic Advances in Gastroenterology;2023-01